HIV Prevention Trials Network

Hiv Prevention Trials Network

Research, , District of Columbia, Washington, 20036, United States, 501-1000 Employees

hptn.org

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: +12*********

Who is HIV PREVENTION TRIALS NETWORK

HPTN studies evaluate innovative strategies in populations and geographical regions that bear a disproportionate burden of risk including cisgender women, adolescents and young people, ci...

Read More

map
  • Washington, District of Columbia, 20036, United States Headquarters: Washington, District of Columbia, 20036, United States
  • 1999 Date Founded: 1999
  • 501-1000 Employees: 501-1000
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Research

SIC SIC Code: 8011

checked-icon Does something look wrong? Fix it. | View contact records from HIV PREVENTION TRIALS NETWORK

HIV Prevention Trials Network Org Chart and Mapping

Employees

Ploysai Saengwisit

Simultaneous Conference Interpreter

Nongkran Nanongkhai

Simultaneous Conference Interpreter

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding HIV Prevention Trials Network

Answer: HIV Prevention Trials Network's headquarters are located at , District of Columbia, Washington, 20036, United States

Answer: HIV Prevention Trials Network's phone number is +12*********

Answer: HIV Prevention Trials Network's official website is https://hptn.org

Answer: HIV Prevention Trials Network's revenue is $1 Million to $5 Million

Answer: HIV Prevention Trials Network's SIC: 8011

Answer: HIV Prevention Trials Network has 501-1000 employees

Answer: HIV Prevention Trials Network is in Research

Answer: HIV Prevention Trials Network contact info: Phone number: +12********* Website: https://hptn.org

Answer: HPTN studies evaluate innovative strategies in populations and geographical regions that bear a disproportionate burden of risk including cisgender women, adolescents and young people, cisgender men who have sex with men (MSM), transgender people, and people who use substances at sites located in Asia, Europe, sub-Saharan Africa, and North and South America. Since its inception in 1999, the HPTN has had a long history of successfully conceptualizing, designing, and implementing, complex clinical research studies with a focus on biomedical interventions and integrated strategies to prevent HIV acquisition and transmission with more than 65 clinical research sites (CRSs) globally. The HPTN has long-standing partnerships with pharmaceutical companies, academic researchers worldwide, the Bill and Melinda Gates Foundation and several other organizations. In addition, the HPTN has forged collaborations to develop integrated strategies with PEPFAR, the Centers for Disease Control and Prevention (CDC) and both ministries and departments of health in several countries. HPTN receives its funding from three U.S. National Institutes of Health (NIH): the National Institute of Allergy and Infectious Diseases, the National Institute of Mental Health, and the National Institute on Drug Abuse.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access